Objectives: Standard culture may fail to detect fungal pathogens. Reliance upon this technique alone amidst clinical decline or antifungal therapy can make clinical decision-making and disease-monitoring challenging. This pilot study aims to further evaluate the CF fungal airways burden in recognition of this unmet clinical need. Methods: 16 adult CF patients with a spectrum of fungal disease provided spontaneous sputum samples at a single timepoint to be examined by 3 different techniques: (1) Prolonged fungal cultures (Sabouraud's Dextrose Agar + chloramphenicol and Dermasel Agar incubated at 37ºC 48 h then 30ºC and interpreted at Day 7, D14, D21, D28). (2) Microbiology stain: Calcofluor White (CFW) (3) Cytology stain: Grocott's Methenamine Silver (GMS). Results: Prolonged fungal culture (>D7) yielded a positivity rate of 57% compared to 35% of samples at <D7. However CFW stain revealed fungal elements eg. hyphae, in 75% of samples. GMS stain revealed fungal findings in 73%. Of the fungal culture-negative samples, stains detected fungal elements in up to 50% (CFW 33%, GMS 50%). Conclusion: Whilst the sample size in this preliminary cohort is small, the clinical utility for additional evaluation of fungal disease by a panel of laboratory techniques available to most hospital pathology departments is highlighted. Of note, Scedosporium apiospermum and Exophiala dermatitidis, two emerging fungal pathogens required >D7 culture. GMS stain a had greater detection rate for fungal elements compared to CFW in the fungal culture-negative samples. The evaluation of these techniques in monitoring disease over time and for early detection of fungal infection forms the focus of the next stage of this study.
Although controversial, two brothers showed the same macrorestriction profile and three other patients, without kinship, showed equal pulsotype. All of these patients showed colonization for other bacteria including P. aeruginosa, S. aureus and Bcc.
A. xylosoxidans was 100% sensitive to imipenem, 81.8% to meropenem, 72.7% to piperacillin-tazobactam, 63.6% to ceftazidime, 54.5% to polymyxin B and 9% to ciprofloxacin. In conclusion, our group of patients with A. xylosoxidans showed a very compromised lung function and low Shwachman score without nutritional impairment, whereas bacteria showed a similar sensibility profile to literature. : 2000-2004, 2005-2009 and 2010-2013, were included. All sputum samples referred for microbiological analysis in Queensland in the 12 months prior to and after the date of transition were identified from a statewide pathology database. Rates of Pseudomonas infection, lung function and BMI were analysed with univariate analyses. Gender, location of paediatric care, Pseudomonas isolation at transition, and the number of sputum samples analysed were included in the multivariate analysis. Results: 187 patients were identified. Over the three time points, the percentage of patients with Pseudomonas was 90.8%, 78.9%, and 72.2% respectively (p = 0.021). There were trends towards improvements in BMI, FEV 1 % predicted, and FVC % predicted. These trends were accounted for by the rate of Pseudomonas infection and number of sputum samples referred. Conclusion: Improvements in lung function and nutrition in CF patients transitioning to adult care between 2000 and 2013 are associated with a reduction in rates of Pseudomonas infection, and a reduction in the number of sputa referred for microbiology. This raises the possibility that the improved health of CF patients is as a consequence of reduced rates of Pseudomonas infection at the time of transition.
